Corrigendum to 'FABP4, marker of worse prognosis in cardiovascular disease, induces neutrophil's proatherogenic phenotype which is modulated by semaglutide' [Journal of Molecular and Cellular Cardiology volume 210 (2026) 12-27].

Authors

Sánchez-López, David; García-Vega, David; Viñuela, J E; Ferreirós-Vidal, Isabel; Iglesias-Álvarez, Diego; Martínez-Cereijo, José Manuel; Reija-López, Laura; Fernández-González, Ángel L; González-Juanatey, José R; Eiras, Sonia